MYRIAD GENETICS, INC. Inventory
MYRIAD GENETICS, INC. (MYGN) had Inventory of $30.60 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-07-31
- 2026-06-30: Inventory, Net $30.60M.
- 2026-03-31: Inventory, Net $27.90M.
- 2025-12-31: Inventory, Net $30.60M.
- 2025-09-30: Inventory, Net $31.60M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $30.60M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $27.90M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $30.60M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $31.60M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $28.70M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $28.30M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $27.50M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $26.20M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $26.10M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $24.60M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $22.00M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $25.10M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $22.50M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $21.80M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $20.10M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $19.60M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $15.40M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $15.60M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $15.30M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $18.60M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $17.70M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $24.60M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $27.10M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $26.60M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $29.10M 10-KT · filed 2021-03-16 | |
| 2020-03-31 | $30.80M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $28.10M 10-Q · filed 2020-02-07 | |
| 2019-09-30 | $28.10M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $31.40M 10-KT · filed 2021-03-16 | |
| 2019-03-31 | $31.90M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $33.30M 10-Q · filed 2019-02-06 | |
| 2018-09-30 | $35.90M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $34.30M 10-K · filed 2019-08-13 | |
| 2018-03-31 | $33.40M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $38.20M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $38.90M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $42.20M 10-K · filed 2018-08-24 | |
| 2017-03-31 | $47.40M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $51.30M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $53.90M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $38.30M 10-K · filed 2017-08-09 | |
| 2016-03-31 | $25.30M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $29.10M 10-Q · filed 2016-02-03 | |
| 2015-09-30 | $34.30M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $25.10M 10-K · filed 2016-08-10 | |
| 2015-03-31 | $29.36M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $20.17M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $24.77M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $23.90M 10-K · filed 2015-08-12 | $23.92M 10-K · filed 2014-08-13 |
| 2014-03-31 | $18.91M 10-Q · filed 2014-05-07 | |
| 2013-06-30 | $5.01M 10-K · filed 2014-08-13 | |
| 2013-03-31 | $7.14M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $10.47M 10-Q · filed 2013-02-06 | |
| 2012-09-30 | $10.60M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $11.57M 10-K · filed 2013-08-14 | |
| 2012-03-31 | $10.38M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $10.29M 10-Q · filed 2012-02-01 | |
| 2011-09-30 | $9.70M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $8.22M 10-K · filed 2012-08-15 | $5.67M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |